Alnylam Pharmaceuticals, Inc. (ALNY) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes therapeutics based on ribonucleic acid interference in the United States, Europe, and internationally. The company offers ONPATTRO for hereditary transthyretin-mediated (hATTR) amyloidosis; AMVUTTRA for ATTR and…
Source: Yahoo Finance
Sector & Industry
Alnylam Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Alnylam Pharmaceuticals, Inc. at a Glance
| Company | Alnylam Pharmaceuticals, Inc. |
| Ticker | ALNY |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $266.11 |
| Market cap | $35.61B |
| P/E ratio (trailing) | 46.28 |
| EPS (trailing) | $5.75 |
| 52-week high | $495.55 |
| 52-week low | $197.81 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.30 |
| Return on equity (ROE) | 96.56% |
| Debt-to-equity | 220.62% |
| Average volume | 1.81M |
| Shares outstanding | 133.81M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 2,500 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is Alnylam Pharmaceuticals, Inc.'s current P/E ratio?
- Alnylam Pharmaceuticals, Inc. (ALNY) has a trailing P/E ratio of 46.28 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Alnylam Pharmaceuticals, Inc.'s market capitalisation?
- Alnylam Pharmaceuticals, Inc.'s market cap is $35.61B based on our latest snapshot. See how it ranks by market cap →
- What is ALNY's 52-week range?
- Over the past 52 weeks, ALNY has traded between $197.81 and $495.55. What does the 52-week range mean? →
- How volatile is Alnylam Pharmaceuticals, Inc. compared to the market?
- Alnylam Pharmaceuticals, Inc. has a beta of 0.30, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Alnylam Pharmaceuticals, Inc. pay a dividend?
- Alnylam Pharmaceuticals, Inc. does not currently pay a dividend according to our latest data.
- What exchange is ALNY listed on?
- ALNY is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Alnylam Pharmaceuticals, Inc. in?
- Alnylam Pharmaceuticals, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →